Barriers to Lung Cancer Screening Engagement from the Patient and Provider Perspective.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 30620258.
- Also identified by DOI 10.1148/radiol.2018180212.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Lung cancer remains the leading cause of cancer mortality in the United States. Lung cancer screening (LCS) with low-dose CT reduces mortality among high-risk current and former smokers and has been covered by public and private insurers without cost sharing since 2015. Patients and referring providers confront numerous barriers to participation in screening. To best serve in multidisciplinary efforts to expand LCS nationwide, radiologists must be knowledgeable of these challenges. A better understanding of the difficulties confronted by other stakeholders will help radiologists continue to collaboratively guide the growth of LCS programs in their communities. This article reviews barriers to participation in LCS for patients and referring providers, as well as possible solutions and interventions currently underway.
Medical subject headings
- Early Detection of Cancer
- Health Services Accessibility
- Lung Neoplasms